Arizona COVID-19 updates: Makeshift morgue set up at Banner hospital in central Phoenix Arizona Republic
A nurse in New York City was among the first people in the United States to receive the first dose of the Pfizer-BioNTech COVID-19 vaccine on Monday morning. Shipments were arriving across the country, with the first boxes arriving in Arizona.
Pima County Health Department director tests positive for COVID-19
Arizona reports 4,848 new COVID-19 cases, 108 deaths
Governor expected to tour Phoenix vaccine site
White Mountain Apache Tribe chairwoman among first to receive vaccine
FDA authorizes nation s first at-home, over-the-counter COVID-19 test
CVS will play key role in COVID-19 vaccine rollout
COVID-19 Vaccines: Safe for Immunocompromised Patients? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Dr. Catherine Van Poznak is the co-chair of a new SWOG Cancer Research Network trial that details, for the first time, the incidence of a common bone disease in cancer. view more
Credit: University of Michigan Rogel Cancer Center
PORTLAND, OR - A landmark study by researchers from the SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has found that 2.8 percent of patients on average develop osteonecrosis of the jaw, or ONJ, within three years of starting a common treatment for cancer that has spread to the bone.
Who should not take the covid vaccine? Guide for allergies, cancer, autoimmune disease today.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from today.com Daily Mail and Mail on Sunday newspapers.
Moderna’s COVID-19 vaccine gets panel support, set to become the second cleared by FDA for use in US Karen Weintraub, USA TODAY
Replay Video UP NEXT
An advisory committee to the U.S. Food and Drug Administration has given a thumbs up to the nation s second COVID-19 vaccine.
The independent Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention to support mRNA-1273, a vaccine made in collaboration with the U.S. government by Moderna, a decade-old Cambridge, Massachusetts-based biotechnology company. There s no doubt in my mind – it looks like the benefits outweigh the risks from what I ve seen, said Dr. Steven Pergam, a committee member and infectious disease and vaccine expert at the Fred Hutchinson Cancer Research Center in Seattle, expressing the group s consensus.